Search
01/02/2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations
Cortellini, A, Ricciuti, B, Vaz, VR, Soldato, D, Alessi, JV, Dall'Olio, FG, Banna, GL, Muthuramalingam, S, Chan, S, Majem, M, Piedra, A, Lamberti, G, Andrini, E, Addeo, A, Friedlaender, A, Facchinetti, F, Gorria, T, Mezquita, L, Hoton, D, Valerie, L, Nana, FA, Artingstall, J, Comins, C, Di Maio, M, Caglio, A, Cave, J, McKenzie, H, Newsom-Davis, T, Evans, JS, Tiseo, M, D'Alessio, A, Fulgenzi, CAM, Besse, B, Awad, MM, Pinato, DJ. Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. Journal for ImmunoTherapy of Cancer. 2022; 10(2)DOI:10.1136/jitc-2021-004374. PMID:35173031. IF:10.900(Q1/2D).
01/02/2022
The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients
Dunn, WG, Gu, MXS, Fabre, MA, Cooper, J, Nomdedeu, JF, Koumas, L, Nicolaou, K, Chi, JX, Costeas, P, Vassiliou, GS. The PML-RARA fusion is not detectable in historical blood samples of acute promyelocytic leukaemia patients. ANNALS OF HEMATOLOGY. 2022; 101(2)DOI:10.1007/s00277-021-04472-5. PMID:33650061. IF:3.500(Q2/5D).
01/02/2022
Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology
Diaz-Riera, E, Garcia-Arguinzonis, M, Lopez, L, Garcia-Moll, X, Badimon, L, Padro, T. Urinary Proteomic Signature in Acute Decompensated Heart Failure: Advances into Molecular Pathophysiology. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042344. PMID:35216460. IF:5.600(Q1/3D).
01/02/2022
"The Accessory Ethmoidal Canal Does Not Necessarily Contain an Arterial Structure"
Gras-Cabrerizo, JR, Martel-Martin, M, Villatoro-Sologaistoa, JC, De la Torre, FR, Mirapeix, R, Carrera, A, Montserrat-Gili, JR, Pujol-Olmo, A, Massegur-Solench, H. "The Accessory Ethmoidal Canal Does Not Necessarily Contain an Arterial Structure". ENT-EAR NOSE & THROAT JOURNAL. 2022; 101(2_SUPPL)DOI:10.1177/01455613211049656. PMID:34666559. IF:1.300(Q4/9D).
01/02/2022
Prognostic value of the nodal yield in elective neck dissections in patients with head and neck carcinomas
Leon, X, Venegas, MD, Casasayas, M, Rodriguez, C, Neumann, ED, Holgado, A, Quer, M. Prognostic value of the nodal yield in elective neck dissections in patients with head and neck carcinomas. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(2)DOI:10.1007/s00405-021-06819-0. PMID:33938992. IF:2.600(Q2/3D).
01/02/2022
Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation
Martino, R, Garcia-Cadenas, I, Esquirol, A. Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation. BONE MARROW TRANSPLANTATION. 2022; 57(2)DOI:10.1038/s41409-021-01507-3. PMID:34711914. IF:4.800(Q1/2D).